Friday, July 01, 2022 3:07:57 AM Gregory Zivic, MD @metacollectiveG
Replying to @legalsagecom @justinkeister5 and 3 others
They’re about ready. I believe they’ll go for where the signals are pulling them; UK/Canada. That gets approved quickly and revenues start flowing. Small upfront payment and then pay per boosters. Non responders don’t pay as much = NICE approval. Then move to EMA, FDA
Market Data 
Markets 
AI
